D'ANTONGIOVANNI, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 2.969
AS - Asia 1.668
EU - Europa 1.565
SA - Sud America 281
AF - Africa 99
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.586
Nazione #
US - Stati Uniti d'America 2.881
IT - Italia 688
SG - Singapore 544
CN - Cina 484
HK - Hong Kong 285
BR - Brasile 233
DE - Germania 204
SE - Svezia 167
GB - Regno Unito 90
VN - Vietnam 88
FI - Finlandia 79
BG - Bulgaria 67
AT - Austria 51
FR - Francia 51
CA - Canada 46
TR - Turchia 40
RU - Federazione Russa 37
IN - India 35
JP - Giappone 35
PL - Polonia 34
CI - Costa d'Avorio 33
KR - Corea 31
NL - Olanda 31
MX - Messico 27
IR - Iran 22
SN - Senegal 21
AR - Argentina 19
BD - Bangladesh 18
ZA - Sudafrica 14
UA - Ucraina 13
IQ - Iraq 11
PK - Pakistan 10
PT - Portogallo 10
UZ - Uzbekistan 10
PH - Filippine 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
ES - Italia 7
LT - Lituania 7
CH - Svizzera 6
ID - Indonesia 6
KE - Kenya 6
MA - Marocco 6
NG - Nigeria 6
SA - Arabia Saudita 6
BE - Belgio 5
CL - Cile 4
IE - Irlanda 4
JO - Giordania 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
GH - Ghana 3
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
CO - Colombia 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
UG - Uganda 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
GD - Grenada 1
GR - Grecia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.586
Città #
Dallas 426
Ashburn 407
Singapore 277
Hong Kong 275
Santa Clara 204
Chandler 175
Fairfield 164
Ann Arbor 161
Woodbridge 148
Shanghai 121
Milan 106
Serra 93
Los Angeles 90
New York 83
Pisa 79
Beijing 77
Boardman 76
Sofia 67
Munich 64
Wilmington 62
Seattle 61
Houston 59
London 52
Hefei 49
Florence 42
Cambridge 37
Vienna 37
Lappeenranta 35
Abidjan 33
Lucca 33
Princeton 33
Turku 31
Frankfurt am Main 30
Ho Chi Minh City 29
Lawrence 29
Seoul 29
Rome 28
Warsaw 28
Bremen 24
São Paulo 24
Tokyo 24
Boulder 23
Dakar 21
Montignoso 21
Dong Ket 20
Istanbul 19
Ottawa 19
Redondo Beach 19
Atlanta 18
Medford 18
Ogden 17
Buffalo 16
Montreal 14
Des Moines 13
Livorno 13
Naples 13
Nuremberg 13
Marseille 12
Chicago 10
Brooklyn 9
Cascina 9
Chennai 9
Fuzhou 9
Hanoi 9
Phoenix 9
Poplar 9
Tashkent 9
Izmir 8
Johannesburg 8
Kent 8
Aguascalientes 7
Denver 7
Guangzhou 7
Nanjing 7
San Diego 7
Amsterdam 6
Boston 6
Brasília 6
Brno 6
Changsha 6
Columbus 6
Jacksonville 6
Lagos 6
Mumbai 6
Nairobi 6
Nürnberg 6
Querétaro 6
Toronto 6
Zhengzhou 6
Ankara 5
Baghdad 5
Belo Horizonte 5
Bergamo 5
Brussels 5
Campinas 5
Düsseldorf 5
Helsinki 5
Mexico City 5
Norwalk 5
Redwood City 5
Totale 4.471
Nome #
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 265
Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the beta-Catenin Gene. 226
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 206
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 194
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 194
Retinal defects in mice lacking the autism-associated gene Engrailed-2 181
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 178
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 178
Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell line secretome 172
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 169
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 168
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 167
Dysregulation of PAR1 expression and signaling in a mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene. 167
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 164
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 157
Donepezil improves vascular function in a mouse model of Alzheimer's disease 156
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 152
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 150
TGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells 148
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 147
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 146
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Myriocin Effect on Tvrm4 Retina, an Autosomal Dominant Pattern of Retinitis Pigmentosa 141
Adenosine signaling in the tumor microenvironment 136
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 132
The intestinal barrier in disorders of the central nervous system 130
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 122
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 121
From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease 119
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 117
null 114
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 113
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 104
Intestinal epithelial barrier and neuromuscular compartment in health and disease 103
null 103
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) 103
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease 100
INVOLVEMENT OF NO PATHWAY IN THE VASOACTIVE EFFECTS OF HYDROGEN SULPHIDE ON CONDUCTANCE AND RESISTANCE RAT BLOOD VESSELS 99
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 97
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 96
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 94
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis 92
Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics? 90
The adenosine system at the crossroads of intestinal inflammation and neoplasia 89
Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure 83
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity 83
Pathological Remodeling of the Gut Barrier as a Prodromal Event of High-Fat Diet-Induced Obesity 77
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 70
α-Synuclein in Parkinson's Disease: From Bench to Bedside 60
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 59
Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice 59
Totale 6.734
Categoria #
all - tutte 20.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 15 16 20 57 32 22 48
2021/2022374 12 11 5 9 57 56 35 18 32 36 30 73
2022/2023732 67 116 48 65 50 73 7 74 151 23 48 10
2023/2024719 46 71 101 46 103 104 25 40 31 31 61 60
2024/20251.984 31 54 53 117 135 258 207 83 233 196 218 399
2025/20261.732 198 284 458 308 326 158 0 0 0 0 0 0
Totale 6.734